GlobalData’s Epidemiology and Market Size Database provides an interactive, comprehensive, and analytical view of the global Pharmaceutical market.
The Database has a user-friendly platform that provides flexible data output options. For each Indication, content can be browsed by individual Countries or by Data Type. Output data can be graphically displayed by clicking the “Graph” button. Key markets covered include the US, Japan, France, Germany, Italy, Spain, and the UK. Additional markets, such as Australia, Brazil, Canada, China, India, Mexico, Russia, South Africa, and South Korea, are covered for numerous Indications.
For each Indication, the database offers country-specific forecasts for important data such as Prevalent and/or Incident Cases, Number of Cases treated, and Market Size.
GlobalData uses a patient-based forecasting model to determine the Market Size for Therapeutic Indications. Estimates are based on a number of primary research sources, including Key Opinion Leader (KOL) interviews and Prescriber Surveys, as well as secondary research sources, such as company reports, press releases, published peer-reviewed journal articles, disease registries, and general news media. Data for the base year and forecast years of the model are grounded in the epidemiology and market parameters, with Top- Down validation of the base-year market using company-reported sales.
Clear Navigation Flow, Transparent Methodology and Easy-To-Use Database
- Filter data by a specific country of interest with our View by Country option
- Special populations are indicated in the Data Type drop-down menu
- Patient segmentations are specified in the Advanced Options menu, as well as in output tables
- Sources used for Epidemiology parameters are cited for each Data Type and Country
- Access to analyst support for help with further understanding of the Indication, including Methodology and source reviews
Why Choose Our Epidemiology And Market Size Database?
The database provides you with accurate forecast data. Relevant and detailed patient segmentations are provided for each Indication, enabling you to evaluate the commercial potential of the market. A refined methodology with a focus on granularity and patient segmentations is provided, while remaining consistent across all markets to ensure comparability of patient populations.
The bottom-up approach based on population estimates and Epidemiology data supports the analysis of unmet needs.
Who Can Our Epidemiology And Market Size Database Help?
- Pharmaceutical and Biotechnology Companies
- Venture Capital
- Private Equity Firms
- Investment Banks